Literature DB >> 23827263

Measuring the affordability of medicines: importance and challenges.

L M Niëns1, W B F Brouwer.   

Abstract

The issue of affordability of health care services remains high on the (health) policy agenda. Determining whether health care services are affordable is complex, however, as the concept 'affordability' is inherently normative. With a focus on measuring affordability in low- and middle-income countries, we discuss different methods used to operationalize this concept. Using the example of medicine purchases in Indonesia, we show the choice of method and threshold to have a significant impact on outcomes. We argue it is important to further standardize methods and appropriate threshold use in applied research to increase comparability of results and to facilitate sound assessments of affordability.
Copyright © 2013 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Keywords:  Affordability; Comparison; Medicines; Methodology; Thresholds

Mesh:

Year:  2013        PMID: 23827263     DOI: 10.1016/j.healthpol.2013.05.018

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  16 in total

Review 1.  Defining and Measuring the Affordability of New Medicines: A Systematic Review.

Authors:  Fernando Antoñanzas; Robert Terkola; Paul M Overton; Natalie Shalet; Maarten Postma
Journal:  Pharmacoeconomics       Date:  2017-08       Impact factor: 4.981

2.  A Worldwide Price Comparison of Glaucoma Medications, Laser Trabeculoplasty, and Trabeculectomy Surgery.

Authors:  Peter Y Zhao; Raheem Rahmathullah; Brian C Stagg; Faisal Almobarak; Deepak P Edward; Alan L Robin; Joshua D Stein
Journal:  JAMA Ophthalmol       Date:  2018-11-01       Impact factor: 7.389

Review 3.  Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment.

Authors:  David Beran; Margaret Ewen; Kasia Lipska; Irl B Hirsch; John S Yudkin
Journal:  Curr Diab Rep       Date:  2018-06-16       Impact factor: 4.810

Review 4.  Training global oncologists: addressing the global cancer control problem.

Authors:  Surbhi Grover; Onyinye D Balogun; Kosj Yamoah; Reinou Groen; Mira Shah; Danielle Rodin; Adam C Olson; Jeremy S Slone; Lawrence N Shulman; C Norman Coleman; Stephen M Hahn
Journal:  Front Oncol       Date:  2015-04-08       Impact factor: 6.244

Review 5.  Locally advanced breast cancer - strategies for developing nations.

Authors:  Onyinye D Balogun; Silvia C Formenti
Journal:  Front Oncol       Date:  2015-04-27       Impact factor: 6.244

6.  Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications.

Authors:  Hye-Young Kwon; Hyungmin Kim; Brian Godman
Journal:  Front Pharmacol       Date:  2018-09-03       Impact factor: 5.810

7.  Investigating the exposure of Iranian households to catastrophic health expenditure due to the need to purchase medicines.

Authors:  Mohammadreza Amiresmaili; Zahra Emrani
Journal:  PLoS One       Date:  2019-04-26       Impact factor: 3.240

8.  Studying the impoverishing effects of procuring medicines: a national study.

Authors:  Mohammadreza Amiresmaili; Zahra Emrani
Journal:  BMC Int Health Hum Rights       Date:  2019-07-31

9.  Availability and affordability of new medicines in Latin American countries where pivotal clinical trials were conducted.

Authors:  Núria Homedes; Antonio Ugalde
Journal:  Bull World Health Organ       Date:  2015-07-29       Impact factor: 9.408

10.  Methodological Issues to Consider When Collecting Data to Estimate Poverty Impact in Economic Evaluations in Low-income and Middle-income Countries.

Authors:  Sedona Sweeney; Anna Vassall; Nicola Foster; Victoria Simms; Patrick Ilboudo; Godfather Kimaro; Don Mudzengi; Lorna Guinness
Journal:  Health Econ       Date:  2016-01-15       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.